Published in Hepatitis Weekly, April 3rd, 2000
Sales are expected to increase 6.9% annually from 1999-2004, reaching 2.8 billion. Sales of pediatric vaccines were the largest industry segment, accounting for 64.3% of overall revenues in 1999, and reaching $1.3 billion.
Adult vaccines grew 9.9% annually between 1994-1999 to $711.2 million, an increase of $266 million over the five-year period. Overall domination of the market came from Merck & Company, SmithKline Beecham, Pasteur Merieux Connaught, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.